StockData
MacroGenics Inc logo

MacroGenics Inc (MGNX) stock

MGNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$2.17−0.03 (-1.36%)

Close on Nov 16, 2026Market cap $138.23MP/E –Yield –

MacroGenics cash

Cash and short-term investments held at the end of each period.

MacroGenics's cash was $113.91M at Jun 30, 2026. For fiscal 2025 it was $57.22M, down 68.7% from the year before. Over ten years it grew -11.6% a year on average. The highest annual figure on record is $220.13M in fiscal 2018.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$57.22M-68.7%
FY2024Dec 31, 2024$182.84M+81.1%
FY2023Dec 31, 2023$100.96M-7.3%
FY2022Dec 31, 2022$108.88M-11.8%
FY2021Dec 31, 2021$123.47M-31.8%
FY2020Dec 31, 2020$181.13M+43.2%
FY2019Dec 31, 2019$126.47M-42.5%
FY2018Dec 31, 2018$220.13M+4.0%
FY2017Dec 31, 2017$211.73M+151.8%
FY2016Dec 31, 2016$84.10M-57.1%
FY2015Dec 31, 2015$196.17M+24.5%
FY2014Dec 31, 2014$157.59M+35.3%
FY2013Dec 31, 2013$116.48M+144.0%
FY2012Dec 31, 2012$47.74M-13.5%
FY2011Dec 31, 2011$55.22M+49.7%
FY2010Dec 31, 2010$36.88M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$113.91M-12.8%
Q1 FY2026Mar 31, 2026$66.52M-54.3%
Q4 FY2025Dec 31, 2025$57.22M-68.7%
Q3 FY2025Sep 30, 2025$80.13M-55.4%
Q2 FY2025Jun 30, 2025$130.69M+55.7%
Q1 FY2025Mar 31, 2025$145.57M+81.2%
Q4 FY2024Dec 31, 2024$182.84M+81.1%
Q3 FY2024Sep 30, 2024$179.63M+99.8%
Q2 FY2024Jun 30, 2024$83.93M-22.8%
Q1 FY2024Mar 31, 2024$80.36M-64.2%
Q4 FY2023Dec 31, 2023$100.96M-7.3%
Q3 FY2023Sep 30, 2023$89.90M+7.0%
Q2 FY2023Jun 30, 2023$108.76M+406.6%
Q1 FY2023Mar 31, 2023$224.26M+373.9%
Q4 FY2022Dec 31, 2022$108.88M-11.8%
Q3 FY2022Sep 30, 2022$83.99M-55.9%
Q2 FY2022Jun 30, 2022$21.47M-88.6%
Q1 FY2022Mar 31, 2022$47.33M-78.3%
Q4 FY2021Dec 31, 2021$123.47M-31.8%
Q3 FY2021Sep 30, 2021$190.53M-5.5%
Q2 FY2021Jun 30, 2021$188.97M-3.8%
Q1 FY2021Mar 31, 2021$218.50M+134.8%
Q4 FY2020Dec 31, 2020$181.13M+43.2%
Q3 FY2020Sep 30, 2020$201.64M+28.8%
Q2 FY2020Jun 30, 2020$196.53M+9.0%
Q1 FY2020Mar 31, 2020$93.06M-61.0%
Q4 FY2019Dec 31, 2019$126.47M-42.5%
Q3 FY2019Sep 30, 2019$156.59M-22.4%
Q2 FY2019Jun 30, 2019$180.32M-24.4%
Q1 FY2019Mar 31, 2019$238.64M+19.1%
Q4 FY2018Dec 31, 2018$220.13M+4.0%
Q3 FY2018Sep 30, 2018$201.81M+122.0%
Q2 FY2018Jun 30, 2018$238.66M+104.6%
Q1 FY2018Mar 31, 2018$200.45M+394.7%
Q4 FY2017Dec 31, 2017$211.73M+151.8%
Q3 FY2017Sep 30, 2017$90.88M-17.3%
Q2 FY2017Jun 30, 2017$116.63M–
Q1 FY2017Mar 31, 2017$40.52M–
Q4 FY2016Dec 31, 2016$84.10M–
Q3 FY2016Sep 30, 2016$109.90M–

More MacroGenics figures

See a number that looks wrong?